Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 16 de 16
1.
iScience ; 26(11): 108355, 2023 Nov 17.
Article En | MEDLINE | ID: mdl-38026219

Spirulina, an herbal supplement and popular ingredient in health foods, is a potent stimulant of the immune system. Spirulina use is temporally associated with the onset or exacerbation of Dermatomyositis (DM), an autoimmune connective tissue disease that frequently affects the skin and muscle. In this study, we investigated the effect of Spirulina on peripheral blood mononuclear cells (PBMCs) in DM and Healthy Controls (HCs), showing that Spirulina stimulates Interferon ß (IFNß), Tumor necrosis factor α (TNFα), and Interferon γ (IFNγ) production of DM PBMCs primarily via Toll-Like Receptor 4 (TLR4) activation using ELISA (enzyme linked immunosorbent assay) and flow cytometry. We show that classical monocytes and monocyte-derived dendritic cells are stimulated by Spirulina and are activated via TLR4. Skin from patients with Spirulina-associated DM exhibits an inflammatory milieu similar to that of idiopathic DM but with a stronger correlation of TLR4 and IFNγ.

3.
J Invest Dermatol ; 142(4): 1058-1064.e7, 2022 04.
Article En | MEDLINE | ID: mdl-34710389

Pemphigus vulgaris is an autoimmune blistering disease characterized by autoantibodies that target desmoglein adhesion proteins. Rituximab and corticosteroids are Food and Drug Administration‒approved therapies for pemphigus vulgaris. As newer treatments for pemphigus enter clinical trials, analysis of clinical and serologic outcomes after rituximab therapy as a function of time is essential to guide clinical trial design. In this study, we report detailed temporal and serologic outcomes of rituximab treatment of pemphigus vulgaris. The maximal prevalence of complete remission off oral systemic therapy after a single cycle of rituximab was 32.4% at 12 months or 43.1% by 36 months, including additional rituximab cycles. Using receiver operating characteristic curves to develop prediction models for complete remission after a single cycle of rituximab, >90.7% reduction in average desmoglein 3 ELISA titers from baseline to months 3‒9 was 94% sensitive, and an average absolute titer ≤130 RU/ml between months 3 and 9 was 96% specific, for achievement of complete remission off oral systemic therapy. All patients with negative titers at 6‒9 months ultimately achieved complete remission off oral systemic therapy. This dataset of clinical and serologic outcomes for patients with pemphigus vulgaris after rituximab therapy will facilitate clinical trial planning and also guide clinician and patient expectations after rituximab therapy.


Pemphigus , Adrenal Cortex Hormones/therapeutic use , Autoantibodies , Humans , Immunologic Factors/therapeutic use , Pemphigus/drug therapy , Remission Induction , Rituximab/therapeutic use , Treatment Outcome
4.
Pediatr Dermatol ; 38 Suppl 2: 140-141, 2021 Nov.
Article En | MEDLINE | ID: mdl-34515362

Disseminated Lyme disease requires treatment to prevent severe sequelae, particularly neurologic. We report here a case of disseminated Lyme disease in a patient with skin of color. Pediatric dermatologists must maintain a high clinical suspicion for Lyme disease and be aware of how typical cutaneous findings may appear differently in skin of color.


Lyme Disease , Skin Pigmentation , Child , Disease Progression , Humans , Lyme Disease/diagnosis , Lyme Disease/drug therapy
5.
Ann Transl Med ; 9(5): 434, 2021 Mar.
Article En | MEDLINE | ID: mdl-33842655

Dermatomyositis (DM) is an autoimmune disease that affects the skin, lungs, and muscle. Although the pathogenesis of DM is not completely understood, several environmental triggers have been linked to DM onset or flare. This article specifically examines the effects of herbal supplements, drugs, infections, ultraviolet (UV) radiation, and environmental pollutants on the onset or exacerbation of DM. Herbal supplements such as Spirulina platensis, Aphanizomenon flos-aquae, Chlorella, Echinacea, and Alfalfa have been implicated and are frequently used in health foods. Medications such as hydroxyurea, TNF-α inhibitors, immune checkpoint inhibitors (ICI), and penicillamine, as well as certain viral infections, such as parvovirus B19, coxsackie virus, polyomavirus, Epstein-Barr virus (EBV), hepatitis, influenza, and human immunodeficiency viruses (HIV) have been associated with DM onset. Bacterial infections and vaccinations have also been linked to the development of DM. Additional environmental factors, including UV radiation and air pollutants, such as silica, biological/mineral dust, and particulate air matter from vehicle and industrial emissions, may also play a role in DM pathogenesis. Overall, there is general agreement that an autoimmune attack of the skin, muscle, and lungs in DM can be triggered by various environmental factors and warrants further investigation.

6.
Pediatr Dermatol ; 38(2): 390-394, 2021 Mar.
Article En | MEDLINE | ID: mdl-33426747

BACKGROUND/OBJECTIVES: Head and neck dermatitis after dupilumab therapy for atopic dermatitis has been frequently reported in adults and only rarely in adolescents. No cases detailing disease course and treatment response have previously been described in adolescents. METHODS/RESULTS: This case series presents five adolescent patients who developed new-onset or worsening head and neck dermatitis after dupilumab therapy for atopic dermatitis. All five patients improved after oral antifungal therapy. CONCLUSIONS: The clinical features, treatment response, and potential disease pathogenesis in pediatric patients are described. Adolescents with new-onset head and neck dermatitis after dupilumab therapy may clinically improve with antifungal therapy, suggesting that Malassezia species may be a contributing factor or antifungal therapy may be an effective antiinflammatory agent.


Dermatitis, Atopic , Eczema , Adolescent , Adult , Antibodies, Monoclonal, Humanized , Child , Dermatitis, Atopic/drug therapy , Head , Humans
7.
Proc Natl Acad Sci U S A ; 118(4)2021 01 26.
Article En | MEDLINE | ID: mdl-33431650

The science around the use of masks by the public to impede COVID-19 transmission is advancing rapidly. In this narrative review, we develop an analytical framework to examine mask usage, synthesizing the relevant literature to inform multiple areas: population impact, transmission characteristics, source control, wearer protection, sociological considerations, and implementation considerations. A primary route of transmission of COVID-19 is via respiratory particles, and it is known to be transmissible from presymptomatic, paucisymptomatic, and asymptomatic individuals. Reducing disease spread requires two things: limiting contacts of infected individuals via physical distancing and other measures and reducing the transmission probability per contact. The preponderance of evidence indicates that mask wearing reduces transmissibility per contact by reducing transmission of infected respiratory particles in both laboratory and clinical contexts. Public mask wearing is most effective at reducing spread of the virus when compliance is high. Given the current shortages of medical masks, we recommend the adoption of public cloth mask wearing, as an effective form of source control, in conjunction with existing hygiene, distancing, and contact tracing strategies. Because many respiratory particles become smaller due to evaporation, we recommend increasing focus on a previously overlooked aspect of mask usage: mask wearing by infectious people ("source control") with benefits at the population level, rather than only mask wearing by susceptible people, such as health care workers, with focus on individual outcomes. We recommend that public officials and governments strongly encourage the use of widespread face masks in public, including the use of appropriate regulation.


COVID-19 , Contact Tracing , Masks , SARS-CoV-2 , COVID-19/epidemiology , COVID-19/prevention & control , Humans
9.
J Am Acad Dermatol ; 84(4): 1051-1058, 2021 Apr.
Article En | MEDLINE | ID: mdl-32553683

The use of herbal supplements that promise to improve immune health has gained popularity among dermatology patients. However, there is little to no evidence that herbal supplements improve dermatologic conditions. Several in vitro and in vivo studies have shown that Spirulina platensis, Aphanizomenon flos-aqua, Chlorella, Echinacea, and alfalfa activate immune cells via certain cytokines and chemokines. Case reports suggest the association of ingesting immunostimulatory herbs and the clinical onset or flares of diseases characterized by an exaggerated immune response such as lupus erythematosus, dermatomyositis, and autoimmune blistering disorders. Therefore, it is imperative to investigate the prevalence of herbal supplement use in this patient population. In addition, in vitro studies should examine the underlying mechanisms by which herbs stimulate immune pathways that are already overactive in autoimmune patients.


Adjuvants, Immunologic/adverse effects , Autoimmune Diseases/chemically induced , Dietary Supplements/adverse effects , Skin Diseases/chemically induced , Adjuvants, Immunologic/pharmacology , Animals , Aphanizomenon , Autoimmune Diseases/immunology , Autoimmune Diseases/physiopathology , Chlorella , Cytokines/metabolism , Disease Progression , Echinacea/adverse effects , Humans , Medicago sativa/adverse effects , Skin Diseases/immunology , Skin Diseases/physiopathology , Spirulina
13.
Int J Dermatol ; 59(11): 1401-1408, 2020 Nov.
Article En | MEDLINE | ID: mdl-32966597

Today, parents are warned to protect their children from the sun's ultraviolet (UV) rays, the most preventable and leading cause of skin cancer. Yet, during the first half of the 20th century, the medical community widely extolled the health benefits of daily sunbaths for babies and children. What initially had begun as evidence-based medical therapies to prevent pediatric diseases, specifically tuberculosis and rickets, soon took on a life of its own as physicians, public health experts, and the general public embraced sunbathing and tanning as a means to ensure health and wellbeing for children and families. Here, we trace how specific medical therapies entered mainstream pediatric medicine and, converging with societal and cultural forces, shaped attitudes and behaviors towards sunbathing that still exist today. Understanding our complex history with the sun may shed light on the current peak of skin cancer incidence and future disease development. Moreover, it may help improve how we educate parents and children about sun safety by taking into account the current social and cultural context of medical practice and health communication.


Skin Neoplasms , Sunbathing , Child , Health Knowledge, Attitudes, Practice , Humans , Phototherapy , Skin Neoplasms/drug therapy , Skin Neoplasms/prevention & control , Sunscreening Agents/therapeutic use , Ultraviolet Rays
15.
Proc Natl Acad Sci U S A ; 117(22): 11875-11877, 2020 06 02.
Article En | MEDLINE | ID: mdl-32404416

Speech droplets generated by asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are increasingly considered to be a likely mode of disease transmission. Highly sensitive laser light scattering observations have revealed that loud speech can emit thousands of oral fluid droplets per second. In a closed, stagnant air environment, they disappear from the window of view with time constants in the range of 8 to 14 min, which corresponds to droplet nuclei of ca. 4 µm diameter, or 12- to 21-µm droplets prior to dehydration. These observations confirm that there is a substantial probability that normal speaking causes airborne virus transmission in confined environments.


Air Microbiology , Betacoronavirus/physiology , Coronavirus Infections/transmission , Pneumonia, Viral/transmission , Saliva/virology , COVID-19 , Dynamic Light Scattering , Fomites/virology , Humans , Pandemics , Particle Size , Severe acute respiratory syndrome-related coronavirus , SARS-CoV-2 , Saliva/chemistry , Speech , Viral Load
...